Elevance Health, Inc.:  How Is The Expansion of Value-Based Care Initiatives Panning Out? 

Elevance Health recently reported its first-quarter results for the 2024 fiscal year, showcasing a blend of strategic accomplishments and agile responses to ongoing industry shifts. The company announced earnings per share (EPS) on a GAAP basis of $9.59 and an adjusted diluted EPS of $10.64, indicating a robust growth of 12.5%. This performance was underpinned by disciplined execution across Elevance Health’s strategic initiatives in a dynamically evolving healthcare landscape.